Professor Peter Goadsby, a neurologist and neuroscientist, has been appointed as Senior Associate to the President and Founding Dean of KAUST's new Division of Biomedical Sciences. He will lead the establishment of the university's fourth academic division, focusing on Biomedical Sciences, and advance the neuroscience department. Goadsby's research identified CGRP as a central driver of migraine, leading to new medicines and earning him the 2021 Brain Prize. Why it matters: This appointment strengthens KAUST's and Saudi Arabia's capacity to translate research into healthcare solutions and supports the Kingdom’s Vision 2030 goals in health innovation.
Antonio Adamo is an assistant professor of bioscience in the Biological and Environmental Science and Engineering Division at KAUST. He is highlighted in a KAUST faculty focus. Why it matters: Showcases KAUST's faculty expertise in bioscience.
Pierre Baldi from UC Irvine presented applications of AI to biomedicine, covering molecular-level analysis of circadian rhythms, real-time polyp detection in colonoscopy videos, and prediction of post-operative adverse outcomes. He discussed integrating AI in future AI-driven hospitals. The presentation was likely part of a panel discussion hosted by MBZUAI in collaboration with the Manara Center for Coexistence and Dialogue. Why it matters: This highlights the growing interest in AI applications within the healthcare sector in the UAE, particularly through institutions like MBZUAI.
KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.
MBZUAI Professor Kun Zhang is working on applying AI to understand cause-and-effect relationships in biology, with the goal of accelerating scientific discovery and improving human health. He aims to develop foundation models for biology that can process diverse data types and provide insights into the causes and treatments of health problems. These models could help scientists develop new medicines and preventative measures for diseases. Why it matters: This research has the potential to significantly advance the field of medicine by enabling a deeper understanding of the complex biological processes that underlie disease.
The AI4Bio Workshop at MBZUAI explored the intersection of AI and biology, focusing on AI-driven virtual organisms and foundation models. Eric Xing presented his vision of using AI to simulate biological activities, offering a safer alternative to physical experiments. Researchers like Le Song and Jen Philippe Vert are developing foundation models for biological systems, enhancing drug discovery and bioengineering. Why it matters: This signals the growing importance of AI in advancing biological research and healthcare innovation within the UAE and globally.
MBZUAI Visiting Professor Haiyan Huang is working on bridging biology and AI by incorporating domain knowledge into modeling frameworks. She combines statistical principles, AI tools, and domain expertise to develop scientifically informed and statistically grounded methods. Her work addresses the challenge of extracting meaningful signals from complex biological data. Why it matters: This interdisciplinary approach can lead to more accurate and useful AI models for biological research and healthcare applications in the region.
Sahika Inal is an assistant professor of bioscience at KAUST's Biological and Environmental Science and Engineering Division. She is a faculty member at King Abdullah University of Science and Technology. Why it matters: This highlights KAUST's ongoing investment in attracting research talent in bioscience.